Security key
22663K107
Crinetics Pharmaceuticals, Inc. - COMMON STOCK (CRNX)
CUSIP: 22663K107
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 105,000,216
- Total 13F shares
- 70,656,199
- Share change
- +1,351,027
- Total reported value
- $2,513,959,167
- Put/Call ratio
- 57%
- Price per share
- $35.58
- Number of holders
- 180
- Value change
- +$68,274,571
- Number of buys
- 102
- Number of sells
- 80
Report period
Q4 2023
Institutions
180
Top holders
10
CRNX full security history
Newer quarter: Q1 2024
Previous quarter: Q3 2023
Crinetics Pharmaceuticals, Inc. SEC filings
Crinetics Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 22663K107
Recent filing periods:
Top shareholders of CRNX - Crinetics Pharmaceuticals, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
4.9%
|
5,132,287
|
$152,634,215 | — | 30 Sep 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.6%
|
4,845,717
|
$144,111,623 | — | 30 Sep 2023 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
4%
|
4,225,300
|
$125,660,422 | — | 30 Sep 2023 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
3.5%
|
3,640,235
|
$108,260,589 | — | 30 Sep 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.2%
|
3,407,035
|
$101,325,221 | — | 30 Sep 2023 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
2.8%
|
2,896,074
|
$86,129,241 | — | 30 Sep 2023 | |
| STATE STREET CORP |
13F
|
Company |
2.7%
|
2,852,720
|
$84,839,893 | — | 30 Sep 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.5%
|
2,578,199
|
$76,677,000 | — | 30 Sep 2023 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
2.1%
|
2,178,737
|
$64,795,638 | — | 30 Sep 2023 | |
| FMR LLC |
13F
|
Company |
2%
|
2,140,861
|
$63,669,217 | — | 30 Sep 2023 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
1.6%
|
1,640,692
|
$48,795,000 | — | 30 Sep 2023 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
1.5%
|
1,589,931
|
$47,284,548 | — | 30 Sep 2023 | |
| First Light Asset Management, LLC |
13F
|
Company |
1.5%
|
1,583,329
|
$47,088,204 | — | 30 Sep 2023 | |
| EcoR1 Capital, LLC |
13F
|
Company |
1.5%
|
1,530,263
|
$45,510,022 | — | 30 Sep 2023 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
1.4%
|
1,433,691
|
$42,637,971 | — | 30 Sep 2023 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
1.2%
|
1,275,552
|
$37,934,916 | — | 30 Sep 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
1,269,674
|
$37,764,558 | — | 30 Sep 2023 | |
| PERCEPTIVE ADVISORS LLC |
3/4/5
13F
|
10%+ Owner · Company |
1.2%
from 13F
|
5,321,032
|
$200,336,855 | — | 18 Apr 2022 | |
| Saturn V Capital Management LP |
13F
|
Company |
1.1%
|
1,126,579
|
$33,504,459 | — | 30 Sep 2023 | |
| Cormorant Asset Management, LP |
13F
|
Company |
1%
|
1,101,904
|
$32,770,625 | — | 30 Sep 2023 | |
| Novo Holdings A/S |
13F
|
Company |
1%
|
1,100,000
|
$32,714,000 | — | 30 Sep 2023 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.97%
|
1,018,782
|
$30,298,577 | — | 30 Sep 2023 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.76%
|
792,920
|
$23,581,441 | — | 30 Sep 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.71%
|
744,816
|
$22,150,134 | — | 30 Sep 2023 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.6%
|
633,364
|
$18,836,000 | — | 30 Sep 2023 | |
| Avidity Partners Management LP |
13F
|
Company |
0.58%
|
610,000
|
$18,141,400 | — | 30 Sep 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.57%
|
597,324
|
$17,764,416 | — | 30 Sep 2023 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.56%
|
588,378
|
$17,474,836 | — | 30 Sep 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.53%
|
552,598
|
$16,434,265 | — | 30 Sep 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.49%
|
511,321
|
$15,206,688 | — | 30 Sep 2023 | |
| Commodore Capital LP |
13F
|
Company |
0.48%
|
500,000
|
$14,870,000 | — | 30 Sep 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.47%
|
492,047
|
$14,633,473 | — | 30 Sep 2023 | |
| GW&K Investment Management, LLC |
13F
|
Company |
0.46%
|
482,942
|
$14,363,000 | — | 30 Sep 2023 | |
| MPM BioImpact LLC |
13F
|
Company |
0.46%
|
479,053
|
$14,247,036 | — | 30 Sep 2023 | |
| 5AM Venture Management, LLC |
13F
|
Company |
0.44%
|
462,286
|
$13,748,386 | — | 30 Sep 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.44%
|
461,303
|
$13,719,151 | — | 30 Sep 2023 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.43%
|
450,000
|
$13,383,000 | — | 30 Sep 2023 | |
| Walleye Capital LLC |
13F
|
Company |
0.41%
|
434,910
|
$12,934,223 | — | 30 Sep 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.39%
|
410,941
|
$12,221,385 | — | 30 Sep 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.38%
|
401,953
|
$11,954,082 | — | 30 Sep 2023 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.37%
|
384,685
|
$11,440,532 | — | 30 Sep 2023 | |
| Opaleye Management Inc. |
13F
|
Company |
0.35%
|
370,000
|
$11,003,800 | — | 30 Sep 2023 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.34%
|
361,904
|
$10,763,025 | — | 30 Sep 2023 | |
| Vivo Capital, LLC |
13F
|
Company |
0.33%
|
350,000
|
$10,409,000 | — | 30 Sep 2023 | |
| Laurion Capital Management LP |
13F
|
Company |
0.33%
|
346,637
|
$10,308,984 | — | 30 Sep 2023 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.29%
|
304,120
|
$9,044,529 | — | 30 Sep 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.27%
|
282,599
|
$8,404,494 | — | 30 Sep 2023 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.26%
|
277,208
|
$8,244,165 | — | 30 Sep 2023 | |
| Altium Capital Management LLC |
13F
|
Company |
0.25%
|
262,000
|
$7,791,880 | — | 30 Sep 2023 | |
| Logos Global Management LP |
13F
|
Company |
0.24%
|
250,000
|
$7,435,000 | — | 30 Sep 2023 |
Institutional Holders of Crinetics Pharmaceuticals, Inc. - COMMON STOCK (CRNX) as of Q4 2023
As of 31 Dec 2023,
Crinetics Pharmaceuticals, Inc. - COMMON STOCK (CRNX) was held by
180 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
70,656,199 shares.
The largest 10 holders included
BlackRock Inc., DRIEHAUS CAPITAL MANAGEMENT LLC, FMR LLC, STATE STREET CORP, VANGUARD GROUP INC, Point72 Asset Management, L.P., WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES INC /MD/, JENNISON ASSOCIATES LLC, and T. Rowe Price Investment Management, Inc..
This page lists
180
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
171
Q4 2023 holders
180
Holder diff
9
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.